@article{845779aca507475cb363edd3831181c5,
title = "Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment andfollow-up",
author = "H. Tilly and U. Vitolo and J. Walewski and \{Da silva\}, \{M. Gomes\} and O. Shpilberg and M. Andr{\'e} and M. Pfreundschuh and M. Dreyling",
note = "Funding Information: Dr. Andr{\'e} has reported research funding from Roche, Celgene, Mundipharma and GlaxoSmithKline. Prof. Tilly has reported: advisory board for Celgene, Roche, Seattle Genetics; research grants from Amgen, Celgene; lectures for Celgene, Amgen, Janssen-Cilag. Dr. Vitolo has reported: advisory board for Roche; lectures for Celgene, Mundipharma. Prof. Walewski has reported: advisory board for Mundipharma, Celgene, GlaxoSmithKline, Janssen Cilag; research grants from Roche, GlaxoSmithKline, Mundipharma, Cephalon; lectures for Roche, Mundipharma; travel grants for Roche, Celgene, Genzyme. Dr. Gomes da Silva has reported: consultancy and travel grants from Celgene, Roche. Prof. Shpilberg has reported: research grants from Roche, Janssen. Prof. Pfreundschuh has reported: advisory boards for Roche, Celgene, Pfizer, Onyx; research grants from Roche, Amgen. Prof. Dreyling has reported consultancy/honoraria: Celgene, Janssen, Mundipharma, Pfizer, Roche; research funding to the institution: Celgene, Janssen, Pfizer, Mundipharma, Roche.",
year = "2012",
month = oct,
doi = "10.1093/annonc/mds273",
language = "אנגלית",
volume = "23",
pages = "vii78--vii82",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Elsevier Ltd.",
number = "SUPPL. 7",
}